Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Simphotek logo — Let's make PDT predictable and affordable.

Simphotek

Let's make PDT predictable and affordable.

Founded 2007 United States Newark, United States 6 employees

General Information

Company Name Simphotek
Founded Year 2007
Location United States Newark, United States
Employees 6
Social

BounceWatch is an independent company data service, not affiliated with Simphotek. To contact Simphotek, visit simphotek.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Simphotek

Simphotek, with the slogan Let's make PDT predictable and affordable, utilizes its core modeling technology to provide critical light treatment planning information to physicians. This includes the use of laser light and light drugs to trigger a photo-chemical reaction that effectively eliminates cancer cells. Their focus on Photodynamic Therapy (PDT) aims to offer a less toxic and repeatable treatment alternative to conventional cancer therapies. With the belief that personalized cancer treatment using light can become a standard cure option, Simphotek Inc owns a patented simulation technology for accurate modeling of photonic interactions in photo-activated materials and devices. Established in 2007 and headquartered in the United States, the company envisions PDT as an accessible cancer treatment offered by facilities of all sizes. The last known investment details and investors are not available at this time.

Taxonomy: Photonics technology, Light therapy dosimetry, Photonics simulation software, Photo-active materials, Treatment planning and monitoring software for PDT, Material science consulting, Cancer therapy technology, Light-matter interactions modeling, Photonic materials development, Laser light treatment planning, Cancer treatment innovation, Modeling technology for photo-activated materials, Photonics research, Optimization of novel materials, Simulation technology for photonic interactions

No funding data available for Simphotek yet.

FAQ About Simphotek

Let's make PDT predictable and affordable.
Simphotek was founded in 2007.
Simphotek is headquartered in Newark, United States.
Simphotek has approximately 6 employees.

We're actively collecting intelligence on Simphotek.

Source: BounceWatch company record for Simphotek, https://bouncewatch.com/company/simphotek, updated 27 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes